BF group | Prostate (n = 80, %) | Cervix uteri (n = 54, %) | Breast (n = 29, %) | Uterus (n = 14, %) | Others (n = 68, %) | p value |
---|---|---|---|---|---|---|
Prim. Completion attribute | Â | Â | Â | Â | Â | Â |
 Actual | 30 (37.5 %) | 18 (33.3 %) | 13 (44.8 %) | 3 (21.4 %) | 18 (26.5 %) | 0.283a |
 Anticipated | 43 (53.8 %) | 29 (53.7 %) | 15 (51.7 %) | 9 (64.3 %) | 36 (52.9 % | |
 None | 7 (8.8 %) | 7 (13.0 %) | 1 (3.4 %) | 2 (14.3 %) | 14 (20.6 %) | |
Completion date attribute | Â | Â | Â | Â | Â | Â |
 Actual | 26 (32.5 %) | 12 (22.2 %) | 8 (27.6 %) | 3 (21.4 %) | 20 (29.4 %) | 0.112a |
 Anticipated | 39 (48.8 %) | 19 (35.2 %) | 15 (51.7 %) | 5 (35.7 %) | 24 (35.3 %) | |
 None | 15 (18.8 %) | 23 (42.6 %) | 6 (20.7 %) | 6 (42.9 %) | 24 (35.3 %) | |
First received | Â | Â | Â | Â | Â | Â |
 1999–2004 | 12 (15.0 %) | 11 (20.4 %) | 1 (3.4 %) | 1 (7.1 %) | 19 (27.9 %) | <0.001a |
 2005–2009 | 29 (36.2 %) | 19 (35.2 %) | 19 (65.5 %) | 10 (71.4 %) | 20 (29.4 %) | |
 2010–2015 | 39 (48.8 %) | 24 (44.4 %) | 9 (31.0 %) | 3 (21.4 %) | 29 (42.6 %) | |
Last changed | Â | Â | Â | Â | Â | Â |
 2005–2009 | 4 (5.0 %) | 4 (7.4 %) | 2 (6.9 %) | 0 | 12 (17.6 %) | 0.202a |
 2010–2015 | 76 (95.0 %) | 50 (92.6 %) | 27 (93.1 %) | 14 (100 %) | 56 (82.4 %) | |
Primary completion | Â | Â | Â | Â | Â | Â |
 2000–2004 | 4 (5.5 %) | 0 | 1 (3.6 %) | 0 | 7 (13.0 %) | 0.104a |
 2005–2009 | 10 (13.7 %) | 10 (21.3 %) | 6 (21.4 %) | 0 | 6 (11.1 %) | |
 2010–2015 | 36 (49.3 %) | 27 (57.4 %) | 17 (60.7 %) | 8 (66.7 %) | 28 (51.9 %) | |
 2016+ | 23 (31.5 %) | 10 (21.3 %) | 4 (14.3 %) | 4 (33.3 %) | 13 (24.1 %) | |
Completion year | Â | Â | Â | Â | Â | Â |
 2000–2004 | 2 (3.0 %) | 0 | 0 | 0 | 6 (13.0 %) | 0.027a |
 2005–2009 | 9 (13.6 %) | 9 (27.3 %) | 2 (8.3 %) | 1 (12.5 %) | 9 (19.6 %) | |
 2010–2015 | 31 (47.0 %) | 16 (48.5 %) | 11 (45.8 %) | 5 (62.5 %) | 17 (37.0 %) | |
 2016+ | 24 (36.4 %) | 8 (24.2 %) | 11 (45.8 %) | 2 (25.0 %) | 14 (30.4 %) |